Xencor | 销售成本



Cost Of Sales 更改 日
AbbVie USD 4B 394M 2025-03
Alnylam Pharmaceuticals USD 102.82M 16.91M 2024-12
Amgen USD 3.11B 198M 2024-12
AstraZeneca USD 2.72B 263M 2024-12
Biogen USD 583.5M 55.2M 2024-12
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Cytokinetics 463K 79.14M 2024-09
GlaxoSmithKline GBP 2.56B 162M 2024-12
J&J USD 7.3B 189M 2025-03
MacroGenics USD 5.49M 3.62M 2024-12
Merck USD 2.76B 944M 2025-03
Novartis USD 3.32B 90M 2024-12
Pfizer USD 5.65B 781M 2024-12
Regeneron Pharmaceuticals USD 565.4M 74.3M 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12
Xencor 10.71M 4.56M 2024-09



Xencor 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2025.